High expression of vascular endothelial growth factor is a risk factor for poor response to neoadjuvant Paclitaxel - carboplatin chemotherapy in stage IB3, IIA2, and IIB cervical cancer
{{output}}
Introduction: Cervical cancer ranks among the top causes of death worldwide in gynecological cancers and is among the most prevalent cancers worldwide, particularly in Indonesia. This study aims to prove that high expression of V... ...
